Risky Behaviors among HIV Serodiscordant and Seroconcordant Couples in Yaounde-Cameroon

Research Article | Open Access

  • 1. Department of Biochemistry, University of Dschang, Cameroon
  • 2. Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon
  • 3. Higher Teachers’ Training College, University of Yaoundé I, Cameroon
  • 4. Department of Biochemistry, University of Yaoundé I, Cameroon
  • 5. Public School of medical Laboratory Technicians, Cameroon
+ Show More - Show Less
Corresponding Authors
Céline Nguefeu Nkenfou, Higher Teachers’ Training College, University of Yaoundé I, Yaoundé, Cameroon; Tel: (237) 675573519

Introduction: Serodiscordant HIV couples are an important source of HIV spread in sub-Saharan Africa. To limit the transmission of HIV within couples, UNAIDS has defined many strategies, including unconditional treatment of the infected partner, systematic condom use, assisted reproduction, regular screening of the negative partner. In Cameroon, there is little information on the follow up of HIV serodiscordant and seroconcordant couples. The purpose of this work was to describe risky behaviors within serodiscordant couples.

Method: This cohort study was conducted in five health facilities. The data were collected using a survey form and the blood collected was used to test consenting participants for HIV, HbsAg, HCV, syphilis, and chlamydia. Data were analyzed using the GraphPad Prism 6 software.

Results: Eighteen seroconcordant and fifty tree serodiscordant couples agreed to participate in the study, where women were predominantly infected (56.66%). Serodiscordance was known for 64 months on average. Among serodiscordant couples, 86.79% infected partners were on ARV treatment, among them 10/46 (15.22%) stopped treatment. Sexual relationship existed in 50/53 couples, with non-systematic use of condom in 44 couples (83.01%). Extramarital relationships were reported in 10 of the 23 serodiscordant couples (56.60%) with libido disorders. HBsAg was most present in HIV infected women (11.32 %) while, HIV-uninfected men were most infected with viral hepatitis C (7. 55 %).

Conclusion: This work has highlighted many risky behaviors in serodiscordant couples. It remains essential to provide continuous counselling to serodiscordant couples and to associate systematic STI screening in all cases of HIV/ AIDS serodiscordance.


 Tchakounte C, Nguefeu CN, Tchouangueu TF, Ngoufack MN, Yatchou LG, et al. (2018) Risky Behaviors among HIV Serodiscordant and Seroconcordant Couples in Yaounde-Cameroon. Clin Res HIV/AIDS 6(1): 1049.


•    Risky Behaviors
•    HIV Serodiscordant Couple
•    STIs
•    Yaounde


HIV: Human Immunodeficiency Virus; AIDS: Acquired Immune Deficiency Syndrome; ART: Antiretroviral Therapy; ARVs: Antiretrovirals; STD: Sexually Transmitted Disease; STIs: Sexually Transmitted Infections; UNAIDS: Joint United Nations Programme on HIV/AIDS; UNFPA: United Nations Population Fund; CMA : Centre Médical d’arrondissement; HbsAg : Hepatitis-B surface Antigen; CTA : Approved Treatment Centers; UPEC: HIV Care and Management Unit; ELISA: Enzyme Linked Immunosorbent Assay; TPHA; Treponema Hemagglutination Assay; HCV: Hepatitis C virus


Are and management of Human Immunodeficiency Virus/ Acquired Immunodeficiency Syndrome (HIV/AIDS) pandemic remains a challenge for low-income countries where sexually transmitted diseases are predominantly transmitted in stable couples in which one partner is or is not receiving care for the infection [1]. In sub-saharan Africa, HIV serodiscordance affects one to two-thirds of couples living with HIV [2,3]. In Zambia and Rwanda, for example, new heterosexual infections in adults from serodiscordant couples range from 55.1 to 92.7% [4]. In serodiscordant couples, HIV-negative partners are at a very high risk of becoming infected [5]. HIV acquisition can be fueled by sexually transmitted infections (STIs) that cause ulceration or not. STIs greatly increase the risk of HIV infection by increasing the susceptibility of the exposed person, as well as the infectivity of an HIV-positive person [6]. The presence of an STI in an exposed person increases their susceptibility to HIV, through various mechanisms such as the presence of genital ulcers or local inflammation. For example, the presence of syphilis in an HIV infected person increases the amount of virus in the genital secretions and therefore the risk of contamination of its partners by HIV. This explains the recommendations to offer STI testing before any HIV diagnosis and vice versa [7].

Conscious of the implication of serodiscordance in the occurrence of new cases and the potentiation of the pandemic to HIV / AIDS, WHO through its UNAIDS program has defined strategies for HIV prevention among serodiscordant couples. These strategies include: placing the infected partner on antiretroviral therapy (ARV) unconditionally, using condoms consistently, using ARVs post-exposure and pre-exposure, screening the negative partner on a regular basis, as well as adequate moral support to helping couples manage HIV serodiscordance [8]. The implementation of these strategies is a struggle in Africa because of the lack of a real policy of serodiscordant couple’s management according to the contexts. Thus, many risky behaviors (non- systematic condom usage, extra-marital sex, treatment interruption and co-infections with other STDs) have been reported in several studies including those of Ruzagira et al. 2011 in Uganda [9], Gitonga et al., in kenya in 2012 [10], Guira et al., in 2012 in Burkina Faso and many other authors [11].

In Cameroon, there is no real policy on the management of serodiscordant couples, therefore, the notion of serodiscordance in general, the national prevalence, the profile of STIs, the challenges faced by these couples, sexual behaviors within couples are poorly known and the documentation almost nonexistent. Walque in 2006, is one of the few authors who took an interest in serodiscordant couples in Cameroon where he described sexual behaviors in this group [2].

Do they receive the appropriate support to cope with HIV serodiscordance? Do they practice their sexuality in strict compliance with HIV prevention recommendations at the individual and couple level as envisioned by WHO? The purpose of this work was to describe, 13 years after the study of Walque et al., the risky behaviors in serodiscordant couples that may promote HIV/AIDS transmission to the seronegative partner.


This was a cohort study conducted from September 2016 to December 2017 in five hospitals (District Hospital of Efoulan, Nkoldongo, Biyem-Assi, cité-verte, Obala and CMA of Nkomo).

Serodiscordant couples consulting in one of these hospitals were our study population, including seroconcordant couples as controls. The term couple refers to two persons living in a household and related by marriage or concubinage for a period of at least twelve months and having sex together. The medical records of HIV positive patients were consulted to identify serodiscordant couples, after which they were contacted by telephone. For those who consented, an appointment was made. The data were collected using a questionnaire offered to each partner separately or together. This questionnaire collected sociodemographic data, therapeutic follow-up, knowledge and attitudes regarding HIV/AIDS. Subsequently, each of the partners was blood sampled and the presumed HIV-negative partners were tested for HIV following the national HIV / AIDS screening algorithm: a first rapid test using Determine® HIV1/2 (Abbott Diagnostic Division, Hoofddorp, The Netherlands) and a second confirmatory test with KHB® HIV (Shanghai Kehua Bioengineering Co., Ltd., China). In case of discordant results to these two tests, the sample was re-analysed by ELISA. The presence of HBsAg, anti-HCV antibodies were determined by the LabACON® kit (Hangzhou Biotest Biotech Co., Ltd., China), anti-treponemal antibodies were searched using two kits, TPHA Biolabo and RPR (Biolabo SA, 02160, Maizy France) and anti-Chlamydia trachomatis antigens were investigated by the Immunocomb® Chlamydia trachomatis IgG kit (Orgenics, Israel). The data were entered and analyzed using the GraphPad Prism Version 6 software. The χ2 or Fischer test was used to compare the qualitative variables and the Student’s test to compare the means with a significance level set at 5 %. The study was approved by the National Research Ethics Committee for Human Health (N° 2016/04/ 758/ CE/CNERSH/SP). Before conducting the study, written informed consent was obtained and all identifying information (names, initials.) were then omitted to ensure the confidentiality.


Sociodemographic characteristics of couples

A total of 266 couples were received. Among them, those who accepted to participate were grouped as follows: 60 / 192 couples (31.25%) were serodiscordant and 19 / 74 (25.67%) seroconcordant. Eight couples were excluded, 7 serodiscordant couples (three for subsequent seroconversion of negative partners and 04 for insufficient data), and one seroconcordant couple (for insufficient data). All couples were heterosexual and monogamous. A proportion of 56.60% of women (30) versus 43.39% of men (23) were infected (p = 0.1739). In addition, 60.38% (32) of the couples were married, while 39.62% (21) lived in concubinage for an average of 03 years and 03 months (ranging from one year to 17 years). Serodiscordance was known for 5 years and 2 months on average (min-max from 3 months to 15 years). All respondents reached at least primary level of education. They were more men (8/53) with a university level than women (5/53). The age of women ranged from 17 to 59 years with an average of 32.81; while that of the men was of 22 and 67 years and an average of 41.26. Although 37out of 53 (69.81%) couples wanted children, 18.91% (07/37) did not have children. Nevertheless, 9 couples (16.98%) did not want to have children anymore (Table 1).

ART observance

We observed in this study that seroconcordant couples were more observant for their ARVs treatment compared to serodiscordant couples (P = 0.0225). All seroconcordant couples have not uninterrupted their treatment, while 21.74% (10/46) serodiscordant couples discontinued their treatment. These data are presented in (Table 2).

Sexual behaviors within couples

Of the 53 serodiscordant couples surveyed, sexual intercourse and abstinence were observed in 50/53 (94.34%) and 03/53 (5.66%) couples, respectively. Altered sexual desire or maintenance of sexual desire was equitably distributed (p = 0.4201) at 43.39% (23/53) and 56.60% (30/53) between those who reported sexual desire disorders compare to those with no libido disorders in sero-discordant couples. Among couples who reported sexual desire impairment, 13.04% of couples (03/23) opted for abstinence while sexual intercourse became increasingly rare, ranging from one to two times within three months in 17.39% of them (04/23) and one time in six months for 4.34% (1/23) of couples. Although libido disorders were reported in 50% (09/18) of seroconcordant couples, the frequency of sexual intercourse was on average once per week.

Among serodiscordant and seroconcordant couples where 23/53 and 09/18 couples reported having disorders of sexual desire, 43.47% (10/23) of serodiscordant couples had extramarital relationships compared to 22.22% (02/09) among seroconcordant couples (p= 0.0015). Serodiscordant couples were twice at risk of having extramarital sex when libido disorders were reported than seroconcordant couples (Table 3).

The systematic use of condoms (male only) was mainly reported among seroconcordant couples (10/18) compared to serodiscordant couples (11/53) with respective proportions of around 55.55% and 20.75% (p = 0.0086). Similarly, the condom was more often used in seroconcordant couples (80%) (8/10)) than in sero-discordant couples (60.38% (32/53)) (p = 0.0086). Ten serodiscordant couples (18.86%) said they had never used condom (Table 4).

Prevalence of STIs (viral hepatitis B and C, syphilis and chlamydia)

In general, none of the STIs was more present in HIV infected partners than HIV non infected partners (p = 0.559) Table 5. In HIV-infected women, 13.33% (4/30) were HBV-positive (HBsAg) versus only one among HIV-negative women (1/23(4.3%)) (p = 0.039). HIV-positive women were 3.25 times more likely to be infected with HBV than HIV-negative women. The distribution of the other three STIs (HCV, syphilis and chlamydia) was similar between HIV infected and HIV non infecetd women. In contrast, more HIV-negative men (13.33%, 4/30) were infected with viral hepatitis C (P = 0.039) compared to HIV infected men (4.3%, 1/23). Syphilis was more present in HIV negative men 3/30 (10 %) than HIV positive men (1/23; 4.3%) without significant difference (p= 0.40). Only one case of syphilis and one of chlamydia were reported in HIV positive women and HIV negative men respectively.

A case of HBV and HVC co-infection was observed in an HIV infected man.

Table 1: Sociodemographic characteristics of couples.

  Sero-discordant couples 
(N = 53 couples) 
Sero-concordant couples (N = 18 
Characteristics sub-characteristics Women N(%) Men 
N (%)
N (%)
 N (%)
Educationnel level Primary 25 (47.2) 25 (47.2) 7 (38.88) 3 (16.66)
secondary 25 (47.2) 20 (37.73) 9 (50) 11 (61.11)
university 3 (5.66) 8 (15.09) 2 (11.11) 4 (22.22)
P value   0.2431 0.2913
Desire to procreate Yes 37 (69.8) 37 (69.8) 13 (72.22) 13 (72.22)
No 16 (30.18) 16(30.18) 5 (27.77) 5 (27.77)
P value                            0.8465
HIV status positif 30 (56.60) 23 (43.39) 18 (100) 18 (100)
negative 23 (43.39) 30 (56.60) 0 (0.00) 0 (0.00)
P value   0.1739 NA
Alteration of sexual intercourse Yes 30 (56.60) 30 (56.60) 9 (50) 9 (50)
No 23 (43.39) 23 (43.39) 9 (50) 9 (50)
P value     0.6266    
Marital status married 32 (60.37) 32 (60.37) 10 (55.55) 10 (55.55)
concubinage 21 (39.62) 21 (39.62) 08 (44.44) 08 (44.44)
P value 0.7850
N: Numbers or frequency 
NA: Not Applicable

Table 2: ARVs intake in serodiscordant couples and seroconcordant couples.

Treatment Serodiscordant 
N = 53
N = 18 
P value
Initiation of ARVs 7 (13.20 %) 0 (0.00 %) 0.0225
Without interruption 36 (69.92 %) 18 (100 %)
With interruption 10 (21.74%) 0 (0.00 %)
N: Numbers ; ARVs: Antiretroviral

Table 3: Correlation between sexual desire disorders and Extramarital relationships.

  Sexual desire disorders      
Extramarital relationship Yes N(%) NO. N (%) P value RR OR
Serodiscordant couples 10 (43.47) 13 (56.53) 0.0015 2.00 2.786
Seroconcordant couples 2 (22.22) 7 (77.77)    
N: Numbers; %: percentage; RR: Relative Risk; OR: Odds Ratio

Table 4: Distribution of condom use among serodiscordant and seroconcording couples.

Condon usage Serodiscordants couples
N = 53
Seroconcordants couples
N = 18
P value
Never 10 (18.86 %) 0 (0.00 %) 0.0086
Sometimes 32 (60.37 %) 08 (44.44 %)
Always 11 (20.75%) 10 (55.55 %)



Management and care for HIV serodiscordant couples require careful monitoring of both partners to limit the risk of HIV transmission as well as other STIs [1]. However, the low study participation rate estimated at 68.75% and 74.33% respectively among serodiscordant and sero-concordant couples with HIV, may translate little sensitization of couples for their contribution in care in Cameroon. Greater participation in the study would have made it possible to better appreciate the realities or experiences of HIV serodiscordant couples in Yaounde.

This study has identified some risky sexual practices like poor condom usage, poor therapeutic compliance, and high prevalence of four STIs among serodiscordant couples compared to seroconcordant HIV couples. All HIV-negative partners participating in this study repeated their test at least twice from first testing. In serodiscordant couple, female partners were more infected with HIV than men partners but without the significant difference. This trend was observed in several studies including those of Walque, 2006, Colman-Sarfo et al., 2017 [2,12]. This could be explained by the fact that women are physiologically more susceptible to HIV than men [13]. It should also be remembered that women can, in many cases, be forced to have sex [2].

HIV seroconcordant couples were more compliant to ARV treatment compared to serodiscordant couples where 18.86% (10) of the HIV positive partners discontinued treatment. The main reasons for discontinuation of ARVs were the stock-out in 4 cases (40%) and in 6 cases (60%) discontinuation was due to mental disorders resulting from the non-acceptance of HIV status.

This risky behavior (the interruption of treatment) increases the chance of transmission to the negative partner as stopping the treatment leads to the increase of viral load, therefore the risk of transmission [14]. Previous work done by Troussier and Tourette-Jurgis in 2006 in France showed that the prevalence of sexual desire disorder was twice as high among serodiscordant couples compared with seroconcordant couples [15]. Similarly, Guira et al (2013) in Burkina Faso observed a very high rate of sexual desire disorders in 97.7% discordant couples compared to 56.60% in our study. Sexual desire disorder is justified in all these works mainly by the fear of infection of the negative partner [11]. Specifically, the low frequency of sexual desire disorders in the present study compared to the other two studies could be justified by the increase in the number of CTAs (Approved Treatment Centers), UPECs (HIV care and Management Unit) and their decentralization up to at the lowest level of the health pyramid that provide psychological support to the patient living with HIV [16].

Extramarital relationships (by the seronegative partner), the major consequences of sexual desire disorders in serodiscordant couples, were observed in 18.86% of couples, which represent a risk of exogenous acquisition or transmission not only of HIV, but also of STIs within couples. This result is close to that found in two studies, one in New York and the other in Burkina Faso with respectively 18% and 25% of couples with extramarital relationships [17,11]. It should be noted that this behavior is observed most in the male partner than the female partner in all these studies including the work of Walque in 2006 in 5 African countries (including Cameroon). This could be justified by the fact that in the African context, in almost all cultures, traditional customs encourage men to have multiple partners [18]. Contrary to the work of Bradley et al., 2008 and Guira et al., 2012 where no link was found between libido disorders and extramarital relationships, a correlation has been established in our study between extramarital relationship and sexual desire disorder [17,11]. Serodiscordant couples were twice as likely to have extramarital relationships when libido disorders were reported compared to seroconcordant couples. The frequency of 18.86% of extramarital relationships recorded in this work may not reflect the true trend of this risk behavior among couples because one of the weaknesses of this study was the fact of having interviewed 29 couples (54. 72%) together. In fact, these couples claimed to have nothing to hide and demanded to participate together in the study. All the cases of extramarital affairs reported came from the 45.28% (24/53) couples interviewed separately. These findings suggest an urgent need to strengthen couples’ counselling on a psychological level in order to help them manage serodiscordance [19]. The male condom was more frequently used in seroconcordant couples compared to serodiscordant couples. This can be explained by the fact that both partners who are infected regularly receive advice on infection management, so they can easily apply HIV / AIDS prevention strategies compared to serodiscordant couples where only one partner is involved and benefits from the above mentioned advices. Studies have shown that the correct use of condoms reduces the risk of HIV transmission by 80% [20]. Condom use in a non-systematic way or never as declared by certain serodiscordant couples (79.24%) represents a major endogenous risk for the infection of the seronegative partner. This proportion of 79.24% is higher than that of Guira et al [11] where 59.5% of couples did not use condoms consistently, as well as those of Colman-Sarfo et al [12] where 40% did not use condoms. These findings suggest the need to define specific control strategies for this group in order to limit the spread of HIV infection because even in the case of undetectable viral load of the HIV virus, UNAIDS recommends the consistent use of condoms in serodiscordant couples [1]. The main reason for not using condom was the need to procreate in 69.81% of cases, and this behavior is observed in couples with no children as well as those with children. Moreover, in the African sociocultural context, procreation is a social pressure for the life of a couple [21]. Low medical assistance is therefore unfavorable to procreation without risk of HIV transmission, including STIs to seronegative partners in serodiscordant couples [22,23]. The distribution of STIs in the HIV positive and HIV negative partners showed that, apart from HbsAg which was more present in the HIV-positive partner, the rest of the three STIs were more prevalent in the HIV-negative partner, which is surprising when we know that HIV infection promotes the occurrence of other diseases in the sense that it decreases the immunity [8]. This observation may be justified by the fact that HIV-negative partners may be more susceptible to extramarital relationships, which predisposes them to exogenous exposure to STIs [24]. HIV / AIDS influences the natural history of HBV [25]. In this work, HIV-positive women were more infected with viral hepatitis B than HIV-negative women with a risk estimated at 3.25 times to contract viral hepatitis B when the woman was HIV positive. This co-infection, estimated at 13.33% among women in this work, is greater than 1% found in the work of Dovonou et al., in 2015 in Benin [26]. This difference in outcome could be justified by the difference in distribution of viral hepatitis B according to the regions in sub-Saharan Africa [27]. Although HIV influences the natural history of viral hepatitis C as well [28], HIV-negative men were more infected with viral hepatitis C than HIV positive men. This observation could be explained by the fact that HIV-negative men would engage in extramarital affairs and therefore expose themselves to the risk of acquisition of STDs than HIV infected with reduced libido.

Table 5: Distribution of 04 STIs among HIV positive partners and their HIV-negative partners in serodiscordant couples.

N (%)
N (%)
N (%)
N (%)
N (%)
HIV + partner 6 (11.32 %) 01 (1.88 %) 02 (3.77 %) 00 (00 %) 09 (16.98 %)
HIV - partner 3 (5.66 %) 04 (7. 55 %) 03 (5.66 %) 01 (1.88 %) 11 (20.75 %)
P value (RR) 0.459 (1.57) 0.100 (0.25) 0.757 (0.66) 1 (0.00) 0.589 (0.81)
HbsAg: Hepatitis-B surface antigen; HCV: Hepatitis C virus



In light of the results of this work, which revealed many risky behaviors among serodiscordant couples, it remains essential to define specific HIV/AIDS prevention strategies among serodiscordant couples as a means of limiting new infections. Targeted counselling should be developed to promote assisted and safe reproductive methods in discordant couples who need to procreate. With regard to STIs, it will be necessary to associate their systematic screening not only in serodiscordant partner who is invited to be tested for HIV infection on a regular basis, but also in the general population.


We thank all participants who made this work possible, as well as all the health staff who helped us to recruit the participants.


1. UNAIDS Global report: UNAIDS report on the global AIDS epidemic 2010. Geneva Switzerland. 2010.

2. De Walque. Discordant couples HIV infection among couples in Burkina Faso, Cameroon, Ghana, Kenya and Tanzania. SSRN. 2006 ; 1-28.

3. Cohen MS, McCauley M, Gamble TR. HIV treatment as prevention and HPTN 052. Curr Opin HIV AIDS. 2012; 7: 99-105.

4. Dunkle KL, Stephenson R, Karita E, Chomba E, Kayitenkore K, Vwalika C, et al. New Heterosexually Transmitted HIV Infections in Married or Cohabiting Couples in Urban Zambia and Rwanda: an analysis of Survey and Clinical Data. Lancet. 2008; 371: 2183-2191.

5. Allen S, Meinzen-Derr J, Kautzman M, Zulu I, Trask S, Fideli U, et al. Sexual behavior of HIV discordant couples after HIV counselling and testing. AIDS. 2003;17:733-740.

6. Myron S. Cohen, Nick Hellmann, Jay A. Levy, Kevin DeCock, Joep Lange. The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J Clin Invest. 2008; 118: 1244-1254.

7. Guy La Ruche,Véronique Goulet,Alice Bouyssou,Patrice Sednaoui, Bertille De Barbeyrac,Nicolas Dupin, et al. Epidémiologie actuelle des infections sexuellement transmissibles bactériennes en France. Press Med. 2013. 42; 432–439.

8. World Health Organization. Guidelines on couple HIV testing and counselling including antiretroviral therapy for treatment and prevention in serodiscordant couples : recommendations for a public health approach. Geneva, Switzerland: 2012.

9. Ruzagira E, Wandiembe S, Abaasa A, Bwanika A, Bahemuka U, Amornkul P, et al. HIV incidence and risk factors for acquisition in HIV discordant couples in Masaka, Uganda: an HIV vaccine preparedness study. PLoS One. 2011; 6: 24037.

10. Moses Mwangi Gitonga, Joyce Ballidawa, Samson Ndege. Challenges and Coping Strategies Among Couples of Mixed HIV Status Presenting at a Large Comprehensive Care Center in Eldoret, Kenya. JBAH. 2012; 2: 18-27.

11. Guira O, Tieno H, Sawadogo S, Drabo JY. Sexuality and risk for sexual  transmission of HIV among serodiscordant couples in Ouagadougou, Burkina Faso. Bull Soc Pathol Exot. 2013; 106: 43-47.

12. Kate Coleman-Sarfo, Emmanuel DeGraft Klo. Challenges Faced by HIV Positive Partners Living in Discordance with HIV Negative Partners: A Case Study of 37 Military Hospital. Clinical Research in HIV/ AIDS. 2017; 4: 1-11.

13. Serge-Clotaire Billong,Joseph Fokam, Edson-Joan Billong, Georges Nguefack-Tsague, Marie-Josée Essi,Raoul Fodjo, et al. Distribution épidémiologique de l’infection à VIH chez les femmes enceintes dans les dix régions du Cameroun et implications stratégiques pour les programmes de prévention. Pan Afr Med J. 2015; 20: 79.

14. Supervie V. Antiretroviral drugs-based HIV prevention methods: what impact on the HIV epidemic?. Med Sci (Paris). 2013; 29: 373-82.

15. Troussier T, Tourette-Turjis C. The quality of life from a sexual and emotional point of view has a positive effect on prevention for patients living with HIV. Sexologies. 2006; 15: 165-175.

16. Fred Eboko, Claude Abé, Christian Laurent. Accès décentralisé au traitement du VIH/sida : évaluation de l’expérience camerounaise. Sciences Sociales et Sida. 2010-ANRS.

17. Bradley M, Remien R, Dolezal C. Depression symptoms and sexual HIV risk behavior among serodiscordant couples. Psychosom Med. 2008; 70: 186-191.

18. UNFPA, UNAIDS, UNIFEM, Women and HIV/AIDS: Confronting the Crisis. 2004.

19. Denison JA, O’Reilly KR, Schmid GP, Kennedy CE, Sweat MD. HIV Voluntary Counselling and Testing and Behavioral Risk Reduction in Developing Countries: A Meta-analysis, 1990–2005. AIDS Behav. 2008; 12: 363-373.

20. Weller S, Davis-Beaty K. Condom Effectiveness in Reducing Heterosexual HIV Transition. Review of the Cochrane Library. Cochrane Coll. 2007; 4: 1-22.

21. Rispel LC, Metcalf C, Moody K, Cloete A, Caswell G. Sexual relations and childbearing decisions of HIV-discordant couples: an exploratory study in South Africa and Tanzania. Reprod Health Matters. 2011; 19:184-193.

22. Ohl J, Partisani M, Wittemer C, Schmitt MP, Cranz C, Stoll-Keller F, et al. Assisted reproduction techniques for HIV serodiscordant couples: 18 months of experience. Human Reprod. 2003;18:1244–1249.

23. Jeanine Ohl, Marialuisa Partisani, Christiane Wittemer, Jean-Marie Lang, Ste?phane Viville, Romain Favre. Encouraging results despite complexity of multidisciplinary care of HIV-infected women using assisted reproduction techniques. Human Reproduction. 2005; 20: 3136–3140.

24. Bunnell R, Nassozi J, Marum E, Mubangizi J, Malamba S, Dillon B, et al. Living with discordance: Knowledge, challenges, and relationship strategies of HIV-serodiscordant couples in Uganda. AIDS Care. 2005;17: 999-1012.

25. Amidou S, Dovonou C, Houehanou C, Kpangon A, Ahanhanzo-Glele R, Kpangon J, et al. Impact of HIV status on the overall prevalence of chronic hepatitis B infection in Parakou, Benin. Pan Afr Med J. 2018; 30: 180.

26. Dovonou CA, Amidou SA, Kpangon AA, Traoré YA, Godjedo TP, Satondji AJ, et al. Prevalence of hepatitis B in people infected with HIV in Parakou in Benin. Pan Afr Med J. 2015; 20: 125.

27. Lukhwareni A, Burnett RJ, Selabe SG, Mzileni MO, Mphahlele MJ. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital. J Med Virol. 2009; 81: 406-412.

28. Vallet-Pichard A, Pol S. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection. Journal of Hepatology. 2006; 44: S28-34.

Received : 15 Aug 2019
Accepted : 16 Sep 2019
Published : 18 Sep 2019
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X